60

Jointown Pharmaceutical Group Co LtdSHG 600998 Stock Report

Last reporting period 30 Jun, 2024

Updated 21 Oct, 2024

Last price

Market cap $B

3.576

Middle

Exchange

XSHG - Shanghai Stock Exchange

600998.SS Stock Analysis

60

Uncovered

Jointown Pharmaceutical Group Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

13/100

Low score

Market cap $B

3.576

Dividend yield

6.66 %

Shares outstanding

1 873.87 B

Jointown Pharmaceutical Group Co., Ltd. engages in the manufacture and distribution of pharmaceuticals, traditional Chinese medicine, and medical equipment. The company is headquartered in Wuhan, Hubei and currently employs 29,338 full-time employees. The company went IPO on 2010-11-02. The firm is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Company’s products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The firm mainly provides services to direct sales or franchise stores through its retailing businesses.

View Section: Eyestock Rating